Axovant Sciences (AXON) trading paused for volatility
- S&P 500 closes higher to secure strongest Q1 since 2019
- UBS sees 5 warnings signals on semiconductor chip stocks
- US consumer sentiment tops estimates in March to hit nearly 3-yr high, UMich says
- Reddit (RDDT) stock continues to slide as short-sellers eye stock
- Estée Lauder (EL) climbs as BofA upgrades to Buy on profit recovery expectations
- AMC Entertainment (AMC) enters into an equity distribution agreement
- Kerrisdale Capital is short Microstrategy (MSTR), long bitcoin
- Discover Financial Services (DFS) Announces CEO Resignation
- Intuitive Machines (LUNR) Files for $300M Share Offering, 160M Share Offering by Selling Stockholders
- Timken (TKR) Appoints Tarak Mehta as New CEO
Baird Defends Axovant Sciences (AXON) After Lundbeck; No Change to Outlook
September 22, 2016 1:35 PM EDTBaird analyst Brian Skorney came out to defend Axovant Sciences (NYSE: AXON), which is getting slammed on rival Lundbeck top-line results.
Skorney commented, "Lundbeck reported failure of Phase 3 STARSHINE trial of idolapirdine, a 5-HT6 antagonist, sending shockwaves through Axovant's stock. However, we... More
Axovant Sciences (AXON) Shares Resume Trading, Look to Bounce Higher
September 22, 2016 12:18 PM EDTAxovant Sciences (NYSE: AXON) resumes trading. Shares are down over 24 percent, but bouncing a bit higher.
... More